Fig 5. Plasma levels of lipocalin-2 in patients obtained at a median of 7 (range 5–9) days after ischemic stroke onset.

First, patients were dichotomized into favourable (mRS 0–2) and unfavourable (mRS 3–6) outcomes assessed 90 days after stroke. Second, patients were dichotomized if they had developed post-stroke infections or not. Plots display the median, interquartile range (box), 10^th and 90^th percentiles (whiskers); *p<0.05; **p<0.01. Abbreviation: mRS = modified Rankin Scale